SN.7 May 2011 17:52
Following first quarter results, Evolution Securities reiterated its "add" rating and 750p target price for Smith & Nephew (SN.), the Swiss surgical products and medicals services group. The broker notes that in the run up to the results, there were some concerns in the market about the impact of European austerity measures, the impact of the Japanese natural disasters and the impact of the metal on metal controversy on US BHR sales. The broker said, nevertheless, that in light of these strong set of results, it was confident that management has a "strong and realistic handle on the business". S&N shares edged higher 11p to 691p.